| Ident. | Authors (with country if any) | Title |
|---|
| 000C97 |
Matthew P. Mount ; Yi Zhang ; Mandana Amini ; Steve Callaghan ; Jerzy Kulczycki ; Zixu Mao ; Ruth S. Slack ; Hymie Anisman ; David S. Park | Perturbation of Transcription Factor Nur77 Expression Mediated by Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)* |
| 001133 |
Maria Xilouri [Grèce] ; Elli Kyratzi ; Pothitos M. Pitychoutis ; Zoi Papadopoulou-Daifoti ; Celine Perier ; Miquel Vila ; Matina Maniati ; Ayse Ulusoy ; Deniz Kirik ; David S. Park ; Keiji Wada ; Leonidas Stefanis | Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system. |
| 001145 |
Maxime W. C. Rousseaux ; Paul C. Marcogliese ; Dianbo Qu ; Sarah J. Hewitt ; Sarah Seang ; Raymond H. Kim ; Ruth S. Slack ; Michael G. Schlossmacher ; Diane C. Lagace ; Tak W. Mak ; David S. Park [Corée du Sud] | Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease |
| 001209 |
M. Emdadul Haque ; Matthew P. Mount ; Farzaneh Safarpour ; Elizabeth Abdel-Messih ; Steve Callaghan ; Chantal Mazerolle ; Tohru Kitada ; Ruth S. Slack ; Valerie Wallace ; Jie Shen ; Hymie Anisman ; David S. Park | Inactivation of Pink1 Gene in Vivo Sensitizes Dopamine-producing Neurons to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and Can Be Rescued by Autosomal Recessive Parkinson Disease Genes, Parkin or DJ-1 |
| 001646 |
Arman Lira ; Jerzy Kulczycki ; Ruth Slack ; Hymie Anisman ; David S. Park | Involvement of the Fcγ Receptor in a Chronic N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Dopaminergic Loss* |
| 001B41 |
Tomoko Kanao ; Katerina Venderova ; David S. Park ; Terry Unterman ; Bingwei Lu [États-Unis] ; Yuzuru Imai [Japon] | Activation of FoxO by LRRK2 induces expression of proapoptotic proteins and alters survival of postmitotic dopaminergic neuron in Drosophila |
